KYNB Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
-1474000
-139.4%
3.7M
Cost of Revenue
2.0K
-100.0%
4.1M
Gross Profit
-1476000
-301.1%
-368000
Operating Expenses
16.1M
+19.7%
13.4M
R&D
6.8M
-9.8%
7.6M
SG&A
9.3M
+58.1%
5.9M
Operating Income
-17574000
-27.2%
-13818000
EBITDA
-17563000
-27.3%
-13796000
Net Income
12.0M
+178.8%
-15198000
EPS (Basic)
$2.96
+178.7%
$-3.76
EPS (Diluted)
$2.96
+178.7%
$-3.76
Shares (Diluted)
4.0M
+0.0%
4.0M
Kyntra Bio (KYNB) โ€” Financials